NIH | National Cancer Institute | NCI Wiki  

Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Comment: Revised based on the release of CTRPMICRO-10 to the Production tier.

This page provides an overview of the new and updated data elements in CTRP for the FDAAA Final Rule. NCI is implementing changes has been implementing changes in the following areas of CTRP in support of the FDAAA Final Rule and ClinicalTrials.gov reporting in two phases:

  1. Phase 1 - In May 2017, NCI updated CTRP to support capture and output of the FDAAA Final Rule data elements:
    1. The Protocol Abstraction (PA) web application, used by the CTRO,
    will capture all
    1. captures all new/modified FDAAA Final Rule data elements. 
    Until CTRP Registration is updated, these
    1. These new/modified FDAAA Final Rule data elements
    will need to be
    1. are submitted to
    the CTRO
    1. the CTRO during this phase to update the trial record during new trial/amendment abstractions. 
    Instructions provided below.
    1. CTRP Abbreviated trial imports from ClinicalTrials.gov
    will include the
    1. include the new/modified data elements if already provided on the ClinicalTrials.gov record.
    2. Nightly export of NCI-Sponsored trials from CTRP to the ClinicalTrials.gov Protocol Registration System (PRS)
    will
    1. include the new/modified data elements.
    2. The CTRP-generated XML file
    sent to centers after
    1. that will be available after the processing of a new trial or amendment in CTRP
    will include all
    1. includes all the new/modified FDAAA Final Rule data elements.
    2. The ClinicalTrials.gov PRS "Upload from NCI CTRP"
    will import
    1. feature imports the new/modified data elements, if submitted to the CTRO to update the trial record during new trial/amendment abstraction
    .Exclusions: The CTRP Trial Registration Website and Services will not be able to capture the new/modified data elements directly.  The Trial Summary Report (TSR) will not reflect the new/modified FDAAA Final Rule data elements. Until Phase 2 (see below) is released, this information will need to be submitted to the CTRO to update the trial record during new trial/amendment abstractions in CTRP
    1. .
  2. Phase 2 - In
  3. late July 2017/early
  4. August 2017, NCI updated
  5. CTRP
  6. the CTRP trial registration website and services to support the capture of all
  7. required
  8. FDAAA Final Rule data elements
  9. , as long as they are submitted to CTRP during new trial/amendment registrations
  10. .
    1. CTRP Registration REST services now support services support the submission of the new/modified FDAAA Final Rule data elements directly to CTRP via the REST services.
    2. Cancer Center CTRP users can enter the new/modified FDAAA Final Rule data elements directly to directly in CTRP via the Registration web application. 
    3. The PA web application All FDAAA Final Rule/ClinicalTrials.gov fields are now optional. The "XML Required" field , used by the CTRO was removed.  Note:  The XML Required field was not a FDAAA Final Rule mandatory field.will no longer be available.
  11. Phase 3 - Planned for In August 2017, complete NCI completed implementation including the following:
    1. The Trial Summary Report (TSR) will include includes the new/modified data elements if as applicable.
      The data warehouse (DW) will have the phase value Early Phase 1 instead of O. 

For questions at any time, contact ncictro@mail.nih.gov.

...